Noosa News
Experts hail addition of two more vaccines to nation’s virus portfolio
Rather, Dr Griffin said, it boosted Australia’s “vaccine portfolio”.
“This gives us additional options and given they’re slightly different technologies they’re very complimentary to the two vaccines we already have an agreement for,” he said.
The vaccine candidates secured by Australia
Newly announced:
- Novavax- 40 million doses – currently in stage 2 and 3 clinical trials
- Pfizer- 10 million doses – currently in stage 2 and 3 clinical trials
Previously announced:
- UQ/CSL – 51 million doses – currently in an expanded stage 1 clinical trial
- University of Oxford/ AstraZeneca – 33.8 million doses – currently in stage 2 and 3 clinical trials
“Having an arrangement now for four vaccines gives us a better chance of having a vaccine…
Continue Reading
-
Noosa News19 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News18 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General22 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News21 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops